Performance of the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics
- PMID: 9774570
- PMCID: PMC105306
- DOI: 10.1128/JCM.36.11.3230-3233.1998
Performance of the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics
Abstract
The Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) uses transcription-mediated amplification and hybridization protection assay procedures to qualitatively detect Chlamydia trachomatis rRNA in urine, endocervical swab, and urethral specimens. The performance of the AMP CT was compared to that of cell culture for endocervical swab and urine specimens from women and urethral and urine specimens from men. Analysis of specimens with discrepant results was performed by a combination of reculture, direct fluorescent-antibody (DFA) staining of specimen sediment, and amplification which targeted a different chlamydial rRNA. A total of 800 urine samples were tested by the AMP CT (607 from women and 193 from men), and 7. 1% were positive for C. trachomatis, with a sensitivity of 91.2% and a specificity of 99.6% upon discrepant analysis. A total of 926 swab specimens were tested by culture and AMP CT (717 endocervical swab specimens and 209 urethral swab specimens from men), and 7.7% were positive for C. trachomatis, with a sensitivity and specificity of 100% upon discrepant analysis. The AMP CT is a sensitive and specific nucleic acid hybridization assay for the detection of C. trachomatis in endocervical swab specimens from women, urethral swab specimens from men, and urine specimens from men and women.
Similar articles
-
Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics.J Clin Microbiol. 1996 Jun;34(6):1401-6. doi: 10.1128/jcm.34.6.1401-1406.1996. J Clin Microbiol. 1996. PMID: 8735088 Free PMC article.
-
Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women.J Clin Microbiol. 1998 Feb;36(2):391-4. doi: 10.1128/JCM.36.2.391-394.1998. J Clin Microbiol. 1998. PMID: 9466747 Free PMC article.
-
Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens.J Clin Microbiol. 1999 Jul;37(7):2223-9. doi: 10.1128/JCM.37.7.2223-2229.1999. J Clin Microbiol. 1999. PMID: 10364589 Free PMC article.
-
DNA amplification assays: a new standard for diagnosis of Chlamydia trachomatis infections.Ann Acad Med Singap. 1995 Jul;24(4):627-33. Ann Acad Med Singap. 1995. PMID: 8849200 Review.
-
Addressing Challenges in Chlamydia trachomatis Detection: A Comparative Review of Diagnostic Methods.Medicina (Kaunas). 2024 Jul 30;60(8):1236. doi: 10.3390/medicina60081236. Medicina (Kaunas). 2024. PMID: 39202518 Free PMC article. Review.
Cited by
-
Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region.Can J Infect Dis. 2003 Jan;14(1):35-40. doi: 10.1155/2003/682345. Can J Infect Dis. 2003. PMID: 18159423 Free PMC article.
-
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.Br J Ophthalmol. 2007 Mar;91(3):293-5. doi: 10.1136/bjo.2006.099150. Epub 2006 Oct 18. Br J Ophthalmol. 2007. PMID: 17050583 Free PMC article.
-
Comparative evaluation of BDProbeTec ET, LCx and PACE 2 assays for the detection of Chlamydia trachomatis in urogenital specimens.Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):512-4. doi: 10.1007/s10096-003-0967-6. Epub 2003 Jul 18. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12884065 No abstract available.
-
Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens.J Clin Microbiol. 1999 Oct;37(10):3092-6. doi: 10.1128/JCM.37.10.3092-3096.1999. J Clin Microbiol. 1999. PMID: 10488159 Free PMC article.
-
PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG test: results of a preliminary study and future implications.J Clin Microbiol. 2002 May;40(5):1749-54. doi: 10.1128/JCM.40.5.1749-1754.2002. J Clin Microbiol. 2002. PMID: 11980955 Free PMC article.
References
-
- Bulmer M, van Doornum G J J, Ching S, Peerbooms P G H, Plier P K, Ram D, Lee H H. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J Clin Microbiol. 1996;34:2395–2400. - PMC - PubMed
-
- Centers for Disease Control. Chlamydia trachomatis infection policy guidelines for prevention and control. Morbid Mortal Weekly Rep. 1985;35:535–574.
-
- Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections. Morbid Mortal Weekly Rep. 1993;42(No. RR-12):1–39. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical